Advanced NanoTherapies, Inc. (ANT) is a clinical-stage medical device company founded in 2018 and based in Santa Clara / Los Gatos, California, applying nanoparticle engineering to vascular drug delivery. Its lead program, SirPlux Duo, is a dual-drug drug-coated balloon (DCB) that delivers sirolimus and paclitaxel simultaneously from a proprietary nanoparticle coating to inhibit restenosis in coronary and peripheral arteries, and it has received FDA Breakthrough Device designations for small-vessel coronary artery disease, coronary in-stent restenosis and below-the-knee peripheral lesions. The company builds physical interventional devices rather than software; it operates no developer program and publishes no public API, SDK, webhook surface or machine-readable API contract.
Advanced NanoTherapies is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Medical Technology, Health Care, and Life Sciences.
Advanced NanoTherapies’ developer surface includes engineering blog and 5 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: advanced-nanotherapies
name: Advanced NanoTherapies
description: Advanced NanoTherapies, Inc. (ANT) is a clinical-stage medical device company founded in 2018 and based in Santa
Clara / Los Gatos, California, applying nanoparticle engineering to vascular drug delivery. Its lead program, SirPlux Duo,
is a dual-drug drug-coated balloon (DCB) that delivers sirolimus and paclitaxel simultaneously from a proprietary nanoparticle
coating to inhibit restenosis in coronary and peripheral arteries, and it has received FDA Breakthrough Device designations
for small-vessel coronary artery disease, coronary in-stent restenosis and below-the-knee peripheral lesions. The company
builds physical interventional devices rather than software; it operates no developer program and publishes no public API,
SDK, webhook surface or machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/advanced-nanotherapies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-07'
modified: '2026-09-07'
position: Consuming
tags:
- Company
- Medical Devices
- Medical Technology
- Health Care
- Life Sciences
- Nanotechnology
- Cardiovascular
- Drug Delivery
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://advancednanotherapies.com/
- type: Blog
url: https://advancednanotherapies.com/news/
- type: TermsOfService
url: https://advancednanotherapies.com/terms-of-use/
- type: PrivacyPolicy
url: https://advancednanotherapies.com/privacy-policy/
- type: LinkedIn
url: https://www.linkedin.com/company/advanced-nanotherapies
- type: DomainSecurity
url: security/advanced-nanotherapies-domain-security.yml
x-enrichment:
date: '2026-09-07'
status: minimal
artifacts_added: 2
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: Advanced NanoTherapies is a clinical-stage interventional-device maker whose product is a physical dual-drug coated
balloon (SirPlux Duo), not software - its WordPress marketing site exposes only company, product, news, privacy and terms
pages, api/docs/developer/portal subdomains all NXDOMAIN, and there is no GitHub organization, SDK or machine-readable
contract anywhere on its public surface.
evidence:
- url: https://advancednanotherapies.com/
status: 202
- url: https://advancednanotherapies.com/openapi.json
status: 202
- url: https://advancednanotherapies.com/.well-known/agent-card.json
status: 202
- url: https://api.github.com/search/users?q=advancednanotherapies
status: 200
checked: '2026-09-07'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →